InterventionsHuman trial

Pathophysiological Obesity Phenotype–Guided Evaluation of Efficacy and Safety for GLP-1RA

ADA Scientific Sessions 2026 Abstract

The paper

Yiran Wang, Chu Lin, Linong Ji, Xiaoling Cai

Beijing

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 2610-P

doi.org/10.2337/db26-2610-p

A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026